To perform a meta-analysis of high-quality published trials, randomized and observational, comparing laparoscopic distal gastrectomy (LDG) and open distal gastrectomy (ODG) for gastric cancer. Background: Controversy persists about the clinical utility of minimally invasive techniques for the treatment of gastric cancer. Prospective data is limited to a few small randomized trails. Methods: Studies published from January 1992 to March 2010 that compare LDG and ODG were identified. No restrictions in pathologic stage were applied. All randomized controlled trials (RCTs) were included. Selection of high-quality, nonrandomized comparative studies (NRCTs) was based on a validated tool (Methodological Index for Nonrandomized Studies). Mortality, complications, harvested lymph nodes, operative time, blood loss, and hospital stay were compared using weighted mean differences (WMDs) and odds ratios (ORs). Results: Twenty-five studies were included in the analyses, 6 RCTs and 19 NRCTs, compromising 3055 patients (1658 LDG, 1397 ODG). LDG was associated with longer operative times (WMD 48.3 minutes; P < 0.001) and lower overall complications (OR 0.59; P < 0.001), medical complications (OR 0.49; P = 0.002), minor surgical complications (OR 0.62; P = 0.001), estimated blood loss (WMD −118.9 mL; P < 0.001), and hospital stay (WMD −3.6 days; P < 0.001). Mortality and major complications were similar. Patients in the ODG group had a significantly higher number of lymph nodes harvested (WMD 3.9 nodes; P < 0.001), although the estimated proportion of patients with less than 15 retrieved nodes was similar (OR 1.26, P = 0.09). Conclusions: LDG can be performed safely with a shorter hospital stay and fewer complications than open surgery. The long-term significance of a difference of less than 5 nodes in the number of harvested lymph nodes remains unclear. Lymph node staging appears to be unaffected. These results need to be validated in Western patients with advanced gastric cancer. (Ann Surg 2012;255:446-456) S ince the first minimally invasive distal gastrectomy for gastric cancer reported in 1994, 1 there have been numerous publications evaluating the effectiveness of the laparoscopic approach for gastric cancer. 2 Many controversies remain, including operative indications, adequate tumor resection, lymphadenectomy, postoperative outcome, long-term quality of life, and survival. Such controversies have remained unresolved largely because most laparoscopic gastric resec-From the *
tions for gastric cancer have been reported as parts of retrospective, observational studies and because the randomized controlled trials (RCTs) reported have few patients.
During the last 5 years, a number of meta-analyses on this topic have been published. Some have included the few available RCTs. [3] [4] [5] [6] However, it has been suggested that pooling small RCTs may be unreliable and underpowered when surgical techniques are compared, as potential study and publication bias are more likely to occur. 7, 8 Conflicting results were found between these meta-analyses for postoperative complications and length of hospitalization. To overcome the paucity of prospective randomized evidence, some authors have performed meta-analysis of combined RCTs and nonrandomized comparative studies (NRCTs). 9, 10 There is evidence that estimates derived from high-quality NRCTs may be similar to those derived from RCTs 11 and, when comparing surgical procedures, pooling of high-quality NRCTs may be as accurate as pooling RCTs. 12 However, a few factors may undermine the strength of the results. In the meta-analysis by Hosono et al, 9 the authors did not perform a quality assessment of the NRCTs included. The quality analysis done in the study by Yakoub et al 10 included items not adequate for the outcomes they defined, like tumor histology and grade or long-term follow-up. Neither of them includes studies published after 2007.
The aim of this study is to perform an updated evaluation of all the available high-quality published trials, randomized and observational, comparing LDG and ODG. Potential advantages of each technique were quantified using the meta-analytical method.
METHODS

Eligibility Criteria Types of Studies
All published randomized and nonrandomized comparative trials, written in English language, comparing LDG and ODG with curative intent for gastric adenocarcinoma were evaluated. Both early and advanced gastric cancers were included. Studies were excluded if the study population included diseases other than gastric adenocarcinoma (eg, gastrointestinal stromal tumor, lymphoma, carcinoid) unless the data were presented separately.
If 2 studies from the same institution were identified, the most recent or the most informative was selected, unless they were reports from different time periods or if the data of overlapping patients could be subtracted.
Types of Interventions
For the LDG group, any distal gastrectomy performed in the space generated by an insufflated pneumoperitoneum or by a wall lifting method, with visualization of the operative field mainly through a videolaparoscope was included. If all phases of the operation were performed intracorporeally, the technique was referred as "totally laparoscopic distal gastrectomy" (TLDG). Techniques in which a small (<5 cm) incision was used to facilitate the procedure or to use a hand port, referred to as "laparoscopic-assisted distal gastrectomy" (LADG) or "hand-assisted distal gastrectomy" (HADG), respectively, were also included in the LDG group. As ODG we considered all procedures described as "open" or "conventional" and performed through a standard upper abdominal laparotomy incision.
Studies that included other types of resections (eg, wedge resections, total or proximal gastrectomies) or those that contained palliative resections were excluded unless the data were presented separately.
Types of Outcome Measures
The outcomes measured were 1. Primary: Operative mortality, overall complication rate, and number of harvested lymph nodes. 2. Secondary: Operative time (min), blood loss (mL), and hospital stay (days).
Postoperative complications were classified as medical (cardiovascular, respiratory, or metabolic events; nonsurgical infections; deep venous thrombosis; and pulmonary embolism) or surgical. Furthermore, surgical complications were categorized as major (any anastomotic leak or fistula, any complication that required reoperation, all intra-abdominal collections, and any surgical complication resulting in hospital death) or minor (wound complications, bleeding events, pancreatitis, ileus, delayed gastric emptying, and anastomotic stricture). This classification system of major and minor surgical complications is based on our Memorial Sloan-Kettering Cancer Center complication reporting system. 13, 14 To assess the clinical significance of potential differences in lymph node retrieval, the number of patients with less than 15 nodes harvested was estimated from the average and dispersion parameters reported in each study for the total number of harvested lymph nodes, assuming a normal distribution of retrieved nodes. Comparison between LDG and ODG was done using odds ratios with the event defined as having less than 15 nodes harvested.
Search
A Medline and Embase database search of the English literature was performed using the following MeSH search terms: "stomach neoplasms," "gastrectomy," "laparoscopy," "minimally invasive surgery," "randomized controlled trial," "prospective study," and "comparative study." These terms, and their combination, were also used as key words, as were "gastric cancer," "laparoscopic," and "gastric resection." Special database functions, such as "related articles" and "explosion," were used to maximize the search. References from relevant articles and reviews were manually searched. Because, to our knowledge, the first LDG was reported in 1994, 1 the search was started in 1992. The last search was performed on March 30, 2010.
Data Collection Process
Relevant data were extracted independently from all studies by 2 reviewers (E.V. and V.S.) and included study features, population characteristics, data needed for quality assessment, and the different outcome measures. Population characteristics include the number and type of procedures performed, age, gender, body mass index (BMI), and tumor pathologic variables. Staging is based on the sixth edition of the American Joint Committee on Cancer staging manual. 15 For the purpose of this study, lymph node dissection was classified as D1 and D2, according to the description provided by the authors.
Quality Assessment
RCT were evaluated by individual components based on the Cochrane risk of bias tool. 16 All RCTs were included in the metaanalysis.
The appropriate method to evaluate quality in NRCTs is controversial. For the purposes of this review, we decided to use a modified scale method that allowed us to rank selected reports according to a previously established score system. The Methodological Index for Nonrandomized Studies (MINORS) is an instrument that was developed by a group of practicing surgeons in France and validated specifically for NRCT evaluation. 17 Some modifications were introduced to the MINORS to meet the needs of our study, including the following:
1. Four of the 12 items were not considered; 2 that mainly evaluate the reporting quality of a study and not the validity of the data (statement of the study aim and adequacy of statistical methods) and 2 better suited to assess the validity of long-term outcomes (adequate follow-up period and follow-up loss < 5%). 2. The item referring to sample size calculation was modified to assess the proficiency of the surgical teams and the power given by the actual number of LDG cases. Scoring was assigned as follows: 0 points for less than 20 LDG cases, 1 point for more than 20 but less than 50 cases, and 2 points if 50 or more LDG cases were performed. 3. Other smaller modifications were introduced in the definitions of some items, all shown in Table 1 .
In total, 8 items were evaluated, with a maximum score of 16 points. Studies with 12 or more points were considered as high quality and were included in the meta-analysis. Those with less than 12 points were excluded.
Statistical Analysis
This study was performed in line with the recommendations of the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) Statement. 18 RCT and NCRT are first analyzed separately using a random-effects model 19 and then combined using a stratified analysis. All parameter estimates, confidence intervals, and test of significance were derived from these models using asymptotic approximations. This presentation allowed us to see the contrasts between the combined results of RCTs with those of NCRTs. It also made possible the combination of the RCTs and NCRTs to obtain a single meta-analytic estimate in such a way that RCTs receive more weight due to the inherent homogeneity of their patient populations and resulting estimates. Estimated effect measures were weighted mean differences (WMDs) for continuous data and odds ratio (ORs) for event-related outcomes. Between-study heterogeneity was assessed using Cochran Q statistic. Subgroup analysis was planned for studies with matched lymph node dissection, matched TNM/stage, studies that selected only clinical stage I cancers for LDG, and for the number of LDG cases performed (50 cases cutpoint). All analyses were performed by Comprehensive Meta Analysis Version 2.0 (Biostat Solutions, Inc, Englewood, NJ) and SAS version 9.2 (Statistical Alert System; SAS Institute Inc, Cary, NC). Thirteen NRCTs were excluded after quality assessment, so finally 19 NRCTs were included in the present study.
Quality Assessment
Assessment of RCTs is shown in Table 2 . In general, they suffer from methodologic drawbacks frequently seen in surgical RCTs, mainly difficulties in concealing the allocation of patients and the inherent complexity of blinding between laparoscopic and open cases. Older RCTs also are limited by the small number of patients included. All but one RCT 22 were exclusively in stage I gastric cancer. Table 3 . The median score was 12 points and it was significantly higher for the 15 studies published after 2007 (12 vs 10 points, P = 0.006 by t test). The characteristics of the excluded studies can be accessed online (see Table, Supplemental Digital Content 1 http://links.lww.com/SLA/A226).
Assessment of NRCTs is displayed in
Study Characteristics
The major study features are summarized in Table 4 . A total of 3055 patients were included in the analysis with 1658 undergoing LDG (54%) and 1397 (46%) undergoing ODG. The 6 RCTs contributed 666 cases in total, 343 of them laparoscopic (21% of all LDG). Overall, there were 19 conversions to open surgery (1.1%), 12 of them related to bleeding. Conversion rates for each study varied between 0% and 6.2%. Matching of demographic factors was almost complete and 15 studies were adequately matched in all the factors reviewed. However, 4 studies, all NRCTs, were not matched according to tumor stage 30, 32, 34, 44 and 7 studies, 6 NRCTs and 1 RCT, had differences in the lymphadenectomy performed. 21, 26, 29, 30, 32, 39, 40 As a result, the LDG group had a higher proportion of stage I cancers and D1 dissections than the ODG group (93% vs 83% and 61% vs 31%, respectively) ( Table 5 ). Regarding the preoperative clinical criteria used to select patients for LDG, most studies included only earlystage cancers (stage I) for LDG, although 5 studies, 1 RCT 22 and 4 NRCTs, 27, 41, 42, 44 also included patients with advanced cancers for the laparoscopic technique (Table 4 ). Overall, 2711 patients (89%) were stage I ( Table 5 ).
Primary Outcomes
There was no significant difference in postoperative mortality (OR 0.64, 95% CI [confidence interval] 0.23-1.8, P = 0.39) ( Fig. 2 ). LDG was associated, however, with a significant reduction in overall complications (OR 0.59, 95% CI 0.47-0.74, P < 0.001) ( Fig. 3 ), medical complications (OR 0.49, 95% CI 0.31-0.77, P = 0.002) and minor surgical complications (OR 0.62, 95% CI 0.46-0.83, P = 0.001). Major surgical complications were comparable ( Table 6) . Medical complications were similar in the RCTs (OR ‡Blinding is not possible. Implementation of a protocol for postoperative management was considered the best alternative. §Kim HH, some relevant outcomes (lymph node retrieval, operative time, hospital stay) were not reported. 2006  1  1  2  2  2  2  1  2  13  Hiki 31  2006  1  1  2  1  2  1  2  2  12  Ziqiang 51  2006  1  1  2  0  2  2  2  1  11  Hyodo 52  2007  1  1  1  0  2  2  1  1  9  Nunobe 53  2007  1  1  2  0  2  1  2  1  10  Kiyama 32  2008  2  1  2  0  2  2  1  2  12  Yamada 33  2008  2  1  1  0  2  2  2  2  12  Song KY 34  2008  1  2  2  1  2  2  1  1  12  Song KY 35  2008  1  2  2  2  2  2  2  1  14  Lee WJ 36  2008  1  2  2  0  2  2  2  1  12  Hur 54  2008  1  2  2  0  2  2  1  1  11  Kawamura 37  2008  1  1  2  0  2  2  2  2  12  Chou 38  2008  2  1  2  1  2  2  2  1  13  Kunisaki 39  2009  2  1  2  2  1  2  1  2  13  Yoo 40  2009  1  2  1  2  2  2  1  2  13  Wong 41  2009  2  1  2  2  2  2  1  1  13  Du 55  2009  1  1  2  0  1  2  1  2  10  Hwang 56  2009  1  1  1  2  2  2  1  1  11  Strong 42  2009  1  2  2  0  2  2  2  1  12  Lee JH 43  2009  2  1  2  0  2  2  1  2  12  Lee SE 57  2009  1  1  1  1  2  2  1  2  11  Guzman 44  2009  2  2  2  0  2  2  1  1  12 surgical complications). The retrieval of lymph nodes was significantly higher in the ODG group by 3.9 nodes (95% CI 2.4-5.4, P < 0.001) ( Fig. 4 ). Significant heterogeneity was observed for the difference in lymph nodes in the NRCTs (WMD 2.8, 95% CI 0.6-5.1, P = 0.01, heterogeneity [HG] Q = 80.3, HG P < 0.001) (Fig. 4) . The odds of having less than 15 lymph nodes harvested were comparable (OR 1.26, CI 0.97-1.63, P = 0.09) (see 
Secondary Outcomes
Operation time in the LDG group was longer than that in the ODG group (WMD 48.3 minutes, 95% CI 34.2-62.4, P < 0.001) (Fig. 5) . Estimated blood loss for LDG was less than that of ODG (WMD 118.9 mL, 95% CI 91.1-146.6, P < 0.001) ( Fig. 6) . A shorter hospital stay was observed in the LDG group (WMD 3.6 days, 2.6-4.5, P < 0.001) ( Fig. 7) . Significant heterogeneity was observed for all secondary outcomes in RCTs and NRCTs (Figs. 5-7) . 
Subgroup Analysis
The reduction in overall complications remained significant and with low heterogeneity for all subgroups evaluated. Lymph node retrieval was still higher after ODG in all subgroups with low heterogeneity in all but the subgroup of studies with more than 50 LDG (Q = 20.5, P = 0.02) ( Table 7 ). The overall effects of secondary outcomes remained unchanged in all subgroups, although heterogeneity was still high. Having more than 50 LDG cases performed did not significantly change the overall effect of any outcome, although significant intergroup heterogeneity was observed for the operative time (WMD †One study did not report postoperative complications in the ODG group. ‡Seven studies did not experience/report medical complications. §Three studies did not experience major complications.
countries with mostly early tumors. Mortality was comparable; significant reductions in postoperative complications, intraoperative blood loss, and hospital stay were observed after LDG. Lymph node yield was reduced by 4 nodes in the LDG group, although an uneven distribution of lymphadenectomy type was observed between groups, but the proportion of patients with less than 15 harvested nodes was similar. The most striking finding was of decreased complications in the LDG versus ODG. Although this held true for our meta-analysis, the biggest RCT in our study, from the Korean Laparoscopic Gastrointestinal Surgery Study Group, found no statistical difference in the rate of complications between the laparoscopic and open approach (n = 342; 3.4% difference favoring LDG, P = 0.13). 25 The mean age and BMI of their study group was 55 years and 23.5 kg/m 2 , respectively, whereas 37% had comorbidities and less than 10% had an ASA score of 3. Perhaps no differences were found, as this population is young and healthy. Patients from Western countries have been found to have higher mortality and morbidity rates after open gastric surgery compared to their Eastern counterparts, which is at least partially related to the fact that Asian patients are younger, slimmer, and often healthier at the time of surgery. 58 Age, comorbidities, and obesity, increased visceral fat in particular, have been repeatedly associated with worse postoperative outcomes in studies evaluating open gastrectomy. [59] [60] [61] [62] [63] [64] In contrast, studies that specifically explored these factors in the laparoscopic setting have reported similar rates of complications. 39, [65] [66] [67] [68] [69] [70] [71] Therefore, patients with unfavorable characteristics for conventional surgery may be suitable candidates for the laparoscopic approach. Major surgical complications were not reduced (such as leaks or intra-abdominal abscess), which is consistent with the similar mortality in the 2 groups. This is not surprising because the laparoscopic technique, although less invasive, results in the same organ and lymphatic resection as the open procedure. However, the significantly decreased medical and minor surgical complications could be explained by the reduced invasiveness of the laparoscopic technique and is consistent with the reduction in hospitalization observed in the LDG group. Medical complications were not significantly reduced in the LDG group when only RCTs were analyzed which suggests some degree of selection bias in the NRCT studies, as more healthy patients may have been chosen for LDG. However, overall and minor surgical complications were reduced in both the RCT and NRCT groups and the overall matching was good for demographics and comorbidities. Furthermore, heterogeneity for all the analyses of complications was low in each study type and for the overall estimates. Long-term complications are not analyzed in our study. The reported advantage of laparoscopic approaches in the reduction of complications such as incisional hernias 42 and adhesive bowel obstructions 72, 73 is not evaluated in almost any of these studies, but is an added factor in favor of LDG that should be taken into account. Laparoscopic distal gastrectomy may constitute an attractive approach especially for Western patients and prospective studies should be designed to test this hypothesis in this population.
Reduction in the operative blood loss is a consistent finding in studies comparing laparoscopic and open techniques in many different clinical situations [74] [75] [76] [77] [78] [79] and both the amount of blood loss, as well as the need for transfusions, have been associated with increased perioperative mortality and morbidity. 80, 81 Other data suggest that the amount of operative blood loss and the need of allogenic blood transfusions may negatively impact long-term oncologic outcome of patients undergoing gastrectomy with curative intent, even in patients with early-stage tumors. 82, 83 These findings are not supported by other authors, [84] [85] [86] and whether this represents a biologic effect as opposed to a selection of more complicated cancer resections remains unclear. Although the difference in blood loss in our analysis is only 119 mL, it suggests a consistent difference. In a comparative case-matched study for laparoscopic colectomy, Kiran et al 87 reported that for a 100 mL difference in operative blood loss, a 20% versus 8% transfusion rate was observed for their open and laparoscopic colectomies, respectively, and other authors have confirmed such results. [88] [89] [90] There were not enough data on incidence of transfusions in the studies we analyzed to perform this comparison.
LDG took more time to complete, although patients were discharged earlier from the hospital. As expected, the time required to complete an LDG was lower in the group of studies with more laparoscopic procedures. Although susceptible to bias and local hospital policies, hospital stay reduction after LDG was a consistent finding across all studies. Whether the reduction in hospitalization outweighs the higher costs of the laparoscopic technique is still a matter of much controversy. Adachi et al 91 showed in a small cohort of Japanese patients that the reduction in hospital costs associated with the shorter hospital stay justified the increased cost of performing LADG and was less expensive than ODG. On the contrary, the cost analysis of the small prospective, nonrandomized trial performed by Song et al 35 concluded that both, LADG and TLDG, were more expensive than ODG. In Western countries, cost-analysis studies have been performed for laparoscopic colectomy, which tend to favor the laparoscopic approach, 92, 93 but no studies addressing the economical aspects and cost-effectiveness of laparoscopic gastrectomy have been done.
Oncologic adequacy is the most critical issue when proposing the laparoscopic treatment of gastric cancer. Long-term prospective data is still sparse, 22 and therefore, quality is evaluated by the extent of lymph node dissection performed and the number of harvested lymph nodes. We found that fewer lymph nodes were obtained after LDG. Although the higher proportion of D2 dissections in the ODG group is a limitation of our analysis, the estimates derived from the RCTs only and from the studies matched for lymphadenectomy were similar and leads to us conclude that there is a real difference. An idea about the clinical significance of this finding can be derived from the nonsignificant difference in the estimated proportion of patients with less than 15 lymph nodes harvested, which suggests that pathological staging is not compromised by the laparoscopic technique. This analysis must be interpreted carefully as it is limited by the fact that these are not the actual patients with less than 15 nodes, but a proportion calculated from a model that assumes a normal distribution of the harvested lymph nodes, which may constitute an oversimplification. Whether this small reduction in retrieved lymph nodes has an impact on long-term survival is still unknown and awaits prospective confirmation.
The extent of lymph node dissection has been described as a factor that may lower the number of nodes retrieved after LDG. Miura et al 94 reported a lower compliance rate for nodes along the hepatic, celiac, and splenic arteries and a lesser number of nodes in stations 4, 6, 9, and 11 when laparoscopic D2 dissection was performed, as compared to open surgery. Although D1 dissection is currently accepted as an adequate treatment for selected patients with early gastric cancer based on the low incidence of extraperigastric lymph node metastasis [95] [96] [97] and the results of large retrospective cohorts, 98, 99 D2 dissection is felt to be a more appropriate treatment for patients with advanced disease. 100 D2 dissection is a more technically demanding and time-consuming procedure and concern also exists that a more extensive lymphadenectomy could be associated with higher morbidity. 101 Therefore, it is reasonable to believe that achieving a good D2 laparoscopic lymph node dissection requires a longer learning curve than that for a D1 dissection. To date, all studies referring to the learning curve of distal gastrectomy have basically assessed D1 dissection 40, [102] [103] [104] and one of these studies showed a break in the curve if a more extensive lymphadenectomy was added. 103 Studies are needed to address the learning curve of laparoscopic D2 dissection and factors that may modify it, such as the previous laparoscopic or open D2 experience or the use of robotic devices. This represents a difficult situation especially in Western countries with a low incidence of the disease. We believe that laparoscopic treatment for advanced cancers should be offered only in large specialized centers with experience in advanced laparoscopic procedures and a higher number of patients, so this learning curve can be completed more effectively. 105 Almost all outcomes studied here have been reported to be influenced by learning curve issues. Studies designed to estimate the learning curve have shown a significant reduction in operative time, blood loss, and morbidity and an increase of the lymph node retrieval after 40 to 60 LDG cases. 40, [102] [103] [104] Several of the studies included in our analysis reported on their initial experience, so some outcomes studied, such as operative time or lymph node retrieval may have been influenced by learning curve issues. Unfortunately, most studies did not explicitly describe their previous level of proficiency with the technique, so we were unable to perform a subgroup analysis that directly addressed this matter. As a surrogate, a subgroup analysis was performed using 50 LDG cases as a cut point and demonstrated a significant reduction in the LDG operative time, although the time was still longer than the open procedure. It is likely that we did not observe a more pronounced effect of the number of LDG cases performed because the studies represented, for the large part, the experience of a group of surgeons, whereas the learning curve is an individual achievement.
We are aware that the pooling of data from NRCTs is a debated topic in the field of meta-analysis. 106, 107 NRCTs may exaggerate the effect magnitude of an intervention, either by intrinsic flaws or by external factors such as publication bias. However, some results of previous meta-analyses that only included RCTs were conflicting or incomplete. The studies of Chen et al, 4 Ohtani et al, 5 and Kodera et al 6 did show a reduction in overall complications, whereas Memon et al 3 found no significant difference between the techniques. The study of Kodera et al 6 did not evaluate hospital stay, whereas in the other 3 meta-analyses, hospital stay was 2 to 3 days lower in the LDG group but did not reach statistical significance (P = 0.14 for all studies). Moreover, no subgroup analysis was performed in any of these studies. All this likely relates to the small number of patients and events included. More cases can be obtained if NRCTs are considered, and there is evidence that the pooling of data from well-designed NRCTs may be reliable for surgical procedures. In a review of metaanalyses on laparoscopic colectomy, Abraham et al 12 found that the pooling of NRCTs that included consecutive patients had defined endpoints well, recruited adequate and contemporaneous controls, and collected data prospectively, and among other study characteristics, it generated estimates similar to those calculated from RCTs. 12 These factors are assessed in our quality scale. In our analysis, studies published after 2007 had a significantly better quality score than earlier studies and constitute more than half of the studies included, which are not included in previous meta-analyses with NRCTs. Compared to these previous studies, our analyses share some similarities. Hosono et al 9 reported an overall complication odds ratio of 0.54 (CI 0.37-0.77, P < 0.001) and a 4.4 node (CI 2.9-5.7, P < 0.001) difference in the lymph node yield. They did not perform a quality evaluation of NRCTs. Yakoub et al 10 NRCTs was based on a tool developed for RCT evaluation. In both meta-analyses, only a limited subgroup analysis of complications was done that only showed a lower incidence of postoperative ileus in the study by Hosono et al 9 (OR 0.27, CI 0.09-0.84, P = 0.02). The larger number of patients and events in our study allowed us to perform a more detailed analysis of postoperative complications. Regarding the hospital stay, Hosono et al 9 and Yakoub et al 10 reported a reduction in the LDG of 5.5 and 5.7 days, , respectively, which we believe is an overestimate, even higher than our upper confidence limit (4.5 days). Our estimate of 3.6 days is closer to the difference found in the RCT meta-analyses. Moreover, a 3.8 day difference was estimated for NRCTs only. Perhaps it is in outcomes more prone to bias, such as hospital stay, where the quality of NRCTs has a greater impact in the accuracy of pooled estimates.
In conclusion, LDG is a safe option for the treatment of gastric cancer that compares favorably with ODG in short-term outcomes. LDG may result in a clinically insignificant but lower lymph node retrieval. This may be related to learning curve issues. The long-term oncologic impact of this is unclear. LDG is clearly established as a valid and effective treatment for early gastric cancer in the East. It now needs to be proven for advanced gastric cancer in the West in patients with higher BMI and associated comorbidities. However, Eastern data is highly likely to be replicated.
